Chemoenzymatic synthesis of bacterial nonulosonic acids and glycans
细菌非酮糖酸和聚糖的化学酶法合成
基本信息
- 批准号:10186358
- 负责人:
- 金额:$ 30.91万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2021
- 资助国家:美国
- 起止时间:2021-03-05 至 2025-01-31
- 项目状态:未结题
- 来源:
- 关键词:AcidsAcinetobacter baumanniiAnabolismAnimalsAntibioticsAntibodiesBacteriaBacterial InfectionsBacterial PolysaccharidesBiologicalCarbohydratesCarbonChemicalsComplexConjugate VaccinesDevelopmentEnterobacter cloacaeEnzyme ActivationEnzymesEscherichia coliExcisionFamilyFundingFutureGenerationsGlycoconjugatesGlycosidesImmune systemIn SituKeto AcidsLibrariesLigaseLipopolysaccharidesMammalsMethodsMonitorMonosaccharidesOligosaccharidesPhosphotransferasesPolysaccharidesProcessProductionPropylaminesProteinsReactionReagentResearchRoleSialic AcidsStructureSurfaceSystemUridine Diphosphate GalactoseUridine Diphosphate SugarsVertebral columnVertebratesVirulence Factorschemical synthesiscombatdesignglycosylationglycosyltransferasehost-microbe interactionsimprovedinhibitor/antagonistpathogenic bacteriasugarsugar nucleotidetoolvaccine candidate
项目摘要
Project Summary
Chemoenzymatic synthesis of bacterial nonulosonic acids and glycans
Sialic acids are a family of wide-spread nonulosonic acids (alpha-keto acids with a nine-carbon backbone) in
vertebrates and in some pathogenic bacteria. Bacteria also produce nonulosonic acids that have not been
found in animals. These bacterium-specific nonulosonic acids have been used by bacteria as part of their
capsular polysaccharides (CPSs) and lipopolysaccharides (LPSs) which are bacterial virulence factors and
potential vaccine candidates. Structurally defined bacterial CPSs, LPSs, and the corresponding
oligosaccharide repeating units are important probes to study their roles in bacterial infection and microbe-host
interaction including their influence on host immune systems. These carbohydrates are attractive synthetic
targets but pose significant synthetic challenges. In addition to bacterial specific nonulosonic acids, they may
contain other monosaccharide building blocks that have not been found in mammals. The glycosidic linkages
found in bacterial polysaccharides are also much more diverse than those in mammalian glycans. We propose
to develop efficient chemoenzymatic methods to synthesize bacterial nonulosonic acids and their glycans as
part of CPS and LPS oligosaccharides of pathogenic bacteria. These represent biologically important and
synthetically challenging targets. In the current proposal duration, the focus will be on bacterial glycans
containing legionaminic acid and their derivatives. Three specific aims are: 1, Synthesize acceptors and
monosaccharide chemoenzymatic synthons for one-pot multienzyme (OPME) glycosylation systems; 2,
Identify and characterize candidate sugar-1-P kinases, UDP-sugar synthetases, and glycosyltransferases; and
3, Chemoenzymatic synthesis of bacterial polysaccharide repeating units containing legionaminic acid or
derivatives. The enzymes identified and the monosaccharides designed are important tools and reagents for
accessing synthetic challenging carbohydrates and glycoconjugates that are not limited to the targets
described in the proposal. The oligosaccharides produced are essential probes for better understanding the
important roles of bacterial polysaccharides. They are also candidates for synthesizing structurally defined
carbohydrate-protein conjugate vaccines to combat bacterial infections.
项目概要
细菌非酮糖酸和聚糖的化学酶法合成
唾液酸是广泛分布的非糖酸家族(具有九个碳主链的α-酮酸)
脊椎动物和一些致病细菌。细菌还产生非酮糖酸,这些酸未被
在动物中发现。这些细菌特异性的非酮糖酸已被细菌用作其细菌的一部分。
荚膜多糖(CPS)和脂多糖(LPS)是细菌毒力因子
潜在的候选疫苗。结构明确的细菌 CPS、LPS 以及相应的
寡糖重复单元是研究其在细菌感染和微生物宿主中作用的重要探针
相互作用,包括它们对宿主免疫系统的影响。这些碳水化合物是有吸引力的合成物
目标,但提出了重大的综合挑战。除了细菌特异性的非酮糖酸外,它们还可能
含有在哺乳动物中未发现的其他单糖结构单元。糖苷键
细菌多糖中发现的多糖也比哺乳动物多糖更加多样化。我们建议
开发有效的化学酶方法来合成细菌非糖酸及其聚糖
病原菌的CPS和LPS寡糖的一部分。这些代表了生物学上的重要性和
具有综合挑战性的目标。在当前提案期间,重点将放在细菌聚糖上
含有军团胺酸及其衍生物。三个具体目标是:1、合成受体和
用于一锅多酶(OPME)糖基化系统的单糖化学酶合成子; 2、
鉴定和表征候选糖-1-P激酶、UDP-糖合成酶和糖基转移酶;和
3、化学酶法合成含有军团氨基酸或细菌多糖重复单元
衍生物。鉴定的酶和设计的单糖是重要的工具和试剂
获取不限于目标的合成具有挑战性的碳水化合物和糖复合物
提案中描述。产生的寡糖是更好地了解寡糖的必要探针
细菌多糖的重要作用。它们也是合成结构定义的候选物
碳水化合物-蛋白质结合疫苗可对抗细菌感染。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Xi Chen其他文献
Xi Chen的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Xi Chen', 18)}}的其他基金
Crosstalk between the ER Stress Response and Mitochondrial Fatty Acid Oxidation in MYC-driven Breast Cancer
MYC 驱动的乳腺癌中 ER 应激反应与线粒体脂肪酸氧化之间的串扰
- 批准号:
10581179 - 财政年份:2023
- 资助金额:
$ 30.91万 - 项目类别:
High-throughput closed-loop direct aberration sensing and correction for multiphoton imaging in live animals
用于活体动物多光子成像的高通量闭环直接像差传感和校正
- 批准号:
10572572 - 财政年份:2023
- 资助金额:
$ 30.91万 - 项目类别:
A Life Course Approach to Understanding Racial and Ethnic Disparities in Alzheimer's Disease and Related Dementias and Health Care
了解阿尔茨海默病及相关痴呆症和医疗保健中的种族和民族差异的生命全程方法
- 批准号:
10448032 - 财政年份:2022
- 资助金额:
$ 30.91万 - 项目类别:
Proteostasis Reprogramming in Mutant KRAS-Driven Cancers
突变 KRAS 驱动的癌症中的蛋白质稳态重编程
- 批准号:
10587281 - 财政年份:2022
- 资助金额:
$ 30.91万 - 项目类别:
A Life Course Approach to Understanding Racial and Ethnic Disparities in Alzheimer's Disease and Related Dementias and Health Care
了解阿尔茨海默病及相关痴呆症和医疗保健中种族和民族差异的生命全程方法
- 批准号:
10650381 - 财政年份:2022
- 资助金额:
$ 30.91万 - 项目类别:
Elucidating perifoveal vascular development in infants
阐明婴儿中心凹周围血管发育
- 批准号:
10696178 - 财政年份:2022
- 资助金额:
$ 30.91万 - 项目类别:
Elucidating perifoveal vascular development in infants
阐明婴儿中心凹周围血管发育
- 批准号:
10696178 - 财政年份:2022
- 资助金额:
$ 30.91万 - 项目类别:
Chemoenzymatic construction of synthetic human milk oligosaccharide (HMO) glycome
合成人乳低聚糖 (HMO) 糖组的化学酶法构建
- 批准号:
10567752 - 财政年份:2022
- 资助金额:
$ 30.91万 - 项目类别:
Chemoenzymatic construction of synthetic human milk oligosaccharide (HMO) glycome
合成人乳低聚糖 (HMO) 糖组的化学酶法构建
- 批准号:
10710393 - 财政年份:2022
- 资助金额:
$ 30.91万 - 项目类别:
Chemoenzymatic synthesis of bacterial nonulosonic acids and glycans
细菌非酮糖酸和聚糖的化学酶法合成
- 批准号:
10553186 - 财政年份:2021
- 资助金额:
$ 30.91万 - 项目类别:
相似国自然基金
基因ytnP克隆表达及其对鲍曼不动杆菌的群体淬灭作用及机制研究
- 批准号:82360003
- 批准年份:2023
- 资助金额:32 万元
- 项目类别:地区科学基金项目
抗碳青霉烯耐药鲍曼不动杆菌新型BfmR抑制剂的发现与活性研究
- 批准号:82304377
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
抗CRISPR蛋白抑制CRISPR-Cas系统介导鲍曼不动杆菌耐药和毒力演化机制研究
- 批准号:82373637
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:面上项目
鲍曼不动杆菌抵御黄色黏球菌捕食行为的分子机制与生物学意义
- 批准号:32370114
- 批准年份:2023
- 资助金额:50 万元
- 项目类别:面上项目
鲍曼不动杆菌ATCC 17961 O-抗原、荚膜多糖 K15和K35 抗原的合成及生物活性研究
- 批准号:22377043
- 批准年份:2023
- 资助金额:50 万元
- 项目类别:面上项目
相似海外基金
Chemoenzymatic synthesis of bacterial nonulosonic acids and glycans
细菌非酮糖酸和聚糖的化学酶法合成
- 批准号:
10553186 - 财政年份:2021
- 资助金额:
$ 30.91万 - 项目类别:
Chemoenzymatic synthesis of bacterial nonulosonic acids and glycans
细菌非酮糖酸和聚糖的化学酶法合成
- 批准号:
10364735 - 财政年份:2021
- 资助金额:
$ 30.91万 - 项目类别:
Novel therapeutic approaches for treatment of drug-resistant Gram-positive infections
治疗耐药革兰氏阳性菌感染的新方法
- 批准号:
10301362 - 财政年份:2020
- 资助金额:
$ 30.91万 - 项目类别:
Biochemical Investigations of Sugar-Modifying Enzymes
糖修饰酶的生化研究
- 批准号:
10548737 - 财政年份:2020
- 资助金额:
$ 30.91万 - 项目类别:
Bacterial Cell Wall Composition and the Influence of Antibiotics
细菌细胞壁的组成和抗生素的影响
- 批准号:
10401466 - 财政年份:2016
- 资助金额:
$ 30.91万 - 项目类别: